Search research articles
Contact Us
Filters
Showing results (291-300 of 356) with videos related to
Page
of 36
Sort By:
The Journal of Antimicrobial Chemotherapy
|
May 25, 2023
Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis
Katrien Van Bocxlaer, Jodie Dixon, Johannes J Platteeuw, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
April 21, 2018
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome<sup>®</sup> and AmBisome<sup>®</sup> in murine cutaneous leishmaniasis
Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, et al.
Antimicrobial Agents and Chemotherapy
|
April 2, 2008
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate
N P Dhammika Nanayakkara, Arba L Ager, Marilyn S Bartlett, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2016
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
Diana Tegazzini, Rosario Díaz, Fernando Aguilar, et al.
Experimental Parasitology
|
August 16, 2005
Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase
Livia Vivas, Anna Easton, Howard Kendrick, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
November 25, 2020
Mutually Reinforced Polymer-Graphene Bilayer Membranes for Energy-Efficient Acoustic Transduction
Assad U Khan, Gabriel Zeltzer, Gavriel Speyer, et al.
Bioorganic & Medicinal Chemistry
|
October 15, 2003
2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase
Didier Pez, Isabel Leal, Fabio Zuccotto, et al.
Wellcome Open Research
|
January 11, 2019
Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis
Helen Ashwin, Karin Seifert, Sarah Forrester, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2002
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii
Vanessa Yardley, Anis A Khan, Michael B Martin, et al.
Journal of Medicinal Chemistry
|
August 24, 2000
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines
M O Khan, S E Austin, C Chan, et al.
Page
of 36
Search research articles
Search
Showing results (291-300 of 356) with videos related to
Sort By:
Page
of 36
The Journal of Antimicrobial Chemotherapy
|
May 25, 2023
Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis
Katrien Van Bocxlaer, Jodie Dixon, Johannes J Platteeuw, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
April 21, 2018
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome<sup>®</sup> and AmBisome<sup>®</sup> in murine cutaneous leishmaniasis
Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, et al.
Antimicrobial Agents and Chemotherapy
|
April 2, 2008
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate
N P Dhammika Nanayakkara, Arba L Ager, Marilyn S Bartlett, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2016
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
Diana Tegazzini, Rosario Díaz, Fernando Aguilar, et al.
Experimental Parasitology
|
August 16, 2005
Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase
Livia Vivas, Anna Easton, Howard Kendrick, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
November 25, 2020
Mutually Reinforced Polymer-Graphene Bilayer Membranes for Energy-Efficient Acoustic Transduction
Assad U Khan, Gabriel Zeltzer, Gavriel Speyer, et al.
Bioorganic & Medicinal Chemistry
|
October 15, 2003
2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase
Didier Pez, Isabel Leal, Fabio Zuccotto, et al.
Wellcome Open Research
|
January 11, 2019
Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis
Helen Ashwin, Karin Seifert, Sarah Forrester, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2002
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii
Vanessa Yardley, Anis A Khan, Michael B Martin, et al.
Journal of Medicinal Chemistry
|
August 24, 2000
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines
M O Khan, S E Austin, C Chan, et al.
Page
of 36